Shots:

• OsteoBoost receives the US FDA’s BDD to reduce the risk of osteoporosis. It uses vibration technology that delivers mechanical stimulation to the hips & spine at a precise- individually calibrated frequency- encouraging the body to reduce bone resorption & potentially create new bone
• An initial study showed that just one 30min treatment with OsteoBoost reduced bone loss activity in all participants- showing a decrease of 14%- a reduction on par with bisphosphonate drugs
• The NIH funded a $2M to study for determining the positive effects of OsteoBoost in a larger study with a broader population. The larger study is currently enrolling patients & is scheduled to be completed in early 2022

 ­ Ref: Bone Health Tech | Image: Linkedin